Amarin Corp Plcuk (AMRN) Free Cash Flow Growth (5y) (2015 - 2026)

Amarin Corp Plcuk (AMRN) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.55%
Dec 31, 2025 19.12%
Sep 30, 2025 -25.95%
Jun 30, 2025 59.93%
Mar 31, 2025 -39.09%
Dec 31, 2024 -7.43%
Sep 30, 2024 -16.17%
Jun 30, 2024 -16.79%
Mar 31, 2024 19.85%
Dec 31, 2023 54.29%
Sep 30, 2023 17.72%
Jun 30, 2023 18.07%
Mar 31, 2023 6.50%
Dec 31, 2022 22.20%
Sep 30, 2022 -23.74%
Jun 30, 2022 -43.80%
Mar 31, 2022 -47.98%
Dec 31, 2021 -7.90%
Sep 30, 2021 24.68%
Jun 30, 2021 -11.15%